Physician

Abdullah M Al Dwairi, M.D.

According to 2025 Medicare claims, Abdullah Dwairi, M.D. (NPI: 1639170806) practices infectious disease in the Chico, CA market, with the plurality of this provider's patient population coming from Butte, CA. This provider's primary affiliated billing organization is AMPLA HEALTH (NPI: 1316963606; TIN: 942210447) and primary practice location at 95926-2213. Dwairi is affiliated with the Aledade 45 CA CHC MSSP Enhanced (ACO ID: A4542), participating under the MSSP model.

Dwairi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 34 traditional Medicare patients, billed 42 HCPCS/CPT codes, and received $75 in Medicare payments. The top billing code was 82962 (Blood glucose (sugar) test performed by hand-held instrument). Part D data shows 14,645 prescription claims across 468 beneficiaries totaling $2,376,888 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). DME data shows 295 claims. Open Payments data shows 25 records totaling $429. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $1,808 to $75. Similarly, Part D prescription costs have declined steadily, from $5,614,086 to $2,376,888. For DME billing, reported payments moved sharply higher in recent years, from $34,673 to $47,049.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	59	91	$1,808
2018	20	24	$145
2019	26	28	$157
2020	33	34	$228
2021	50	68	$288
2022	64	116	$387
2023	17	20	$64
2024	34	42	$75

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	311	9,758	$5,614,086
2016	290	9,192	$3,807,282
2017	333	10,469	$3,907,320
2018	339	11,267	$3,244,535
2019	369	11,591	$2,795,267
2020	333	11,465	$2,326,494
2021	354	11,576	$2,392,850
2022	421	11,416	$1,979,825
2023	448	13,176	$2,678,993
2024	468	14,645	$2,376,888

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	70	558	$30,159
2016	104	642	$20,002
2017	99	625	$14,887
2018	90	729	$99,787
2019	77	602	$14,803
2020	68	462	$8,704
2021	57	391	$9,411
2022	43	432	$73,457
2023	41	377	$32,067
2024	47	295	$39,795

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82962	Blood glucose (sugar) test performed by hand-held instrument	15	16	$3
83037	Hemoglobin a1c level, by device for home use	17	19	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	152	4,800	$639,192
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	52	1,860	$234,638
Ozempic	Semaglutide	244	7,448	$225,618
Triumeq	Abacavir/Dolutegravir/Lamivudi	31	1,170	$143,979
Tivicay	Dolutegravir Sodium	33	1,115	$95,827

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	24	$20,536
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	34	$14,478
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	49	$2,879
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	35	96	$822
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	29	$602

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$429	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdullah M. Al Dwairi, M.D.?

Tedicare shows public-source Medicare data for Abdullah M. Al Dwairi, M.D. (NPI 1639170806), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdullah M. Al Dwairi, M.D. have ACO affiliation data?

Abdullah M. Al Dwairi, M.D. is shown with ACO affiliation data for Aledade 45 CA CHC MSSP Enhanced (MSSP, ACO ID A4542).

What billing organization is linked to Abdullah M. Al Dwairi, M.D.?

Abdullah M. Al Dwairi, M.D. is linked to AMPLA HEALTH (billing NPI 1316963606) in the available physician profile data.

Does Abdullah M. Al Dwairi, M.D. have Open Payments data?

Abdullah M. Al Dwairi, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.